Read More
Zydus Lifesciences Reports Q4FY26 Results; EBITDA Margin Expands To 33.7%, ...
Zydus Lifesciences reported Q4FY26 consolidated revenue growth of 16.2 per cent YoY to Rs 7,587 cror...
Articles tagged with "Zydus Lifesciences BSE"
Read More
Parag Parikh Flexi Cap Fund Increased Stake in This Pharma Company; Board t...
Zydus Lifesciences informed exchanges that its board will consider a proposal for buyback of fully p...
Read More
Mid-day movers: InterGlobe Aviation, Ramky Infrastructure and Zydus Lifesci...
Shares of InterGlobe Aviation Ltd, Ramky Infrastructure and Zydus Lifesciences Ltd have rallied in t...